The use of 4-Demethyl-4-cholesteryloxypenclomedine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies Involving the Central Nervous System (CNS)

Authors

  • Morgan, LR

  • Friedlander

  • T

  • Mahmood

  • M

  • Bhandari

  • ML

  • Ware

  • RS

  • Weiner

  • P

Keywords:

Abstract

Abstract not found

How to Cite

The use of 4-Demethyl-4-cholesteryloxypenclomedine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies Involving the Central Nervous System (CNS). (2021). Global Journal of Medical Research, 21(F1), 31-33. https://doi.org/10.34257/GJMRFVOL21IS1PG31

References

Talicia Tarver (2020) Cancer Facts & Figures 2012. American Cancer Society (ACS). 16(3), 366-367.

H Hayes-Lattin (2016) Finding My Community: Building a Strong Network to Improve Sarcoma Care and AYA Oncology in the Philippines.

E Wilson (2016) Brain tumors affect adolescents and young adults differently.

Ark Franklin (2016) A Growing Identity for Adolescent & Young Adult Oncology. 38(21), 1,10,12-12.

E Toronezos (2016) Discussions on adolescent and young adult survivorship. 8-10.

R Weiner, M Ware, T Bhandari, Friedlander, L Morgan (2017) The Tolerance and Safety of 4-Demethyl-4-cholesteryloxypenclomedine [DM-CHOC-PEN] in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies. 3, 1-4.

Lee Morgan, Robert Struck, William Waud, Blaise Leblanc, Andrew Rodgers, Branko Jursic (2009) Carbonate and carbamate derivatives of 4-demethylpenclomedine as novel anticancer agents. 64(4), 829-835.

R Weiner, P Friedlander, C Gordon, Y Saenger, R Ware, T Mahmood, A Rodgers, G Bastian, S Urien, M Bhandari, L Morgan, J-J Zhu (2016) Results of Phase II cancer clinical trials for 4-demethyl-4cholesteryoxycarbonylpenclomedine (DM-CHOC-PEN). 58, 236.

L Morgan, R Weiner, M Ware, M Bhandari, P Mahmood, T Rodgers, Friedlander (2018) Early Phase I Results of 4-Demethyl-4-cholesteryloxypenclomedine [DM-CHOC-PEN] in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies. 7, 75-78.

L Morgan (2017) Commentary on "Weiner et al, The Tolerance and Safety of 4-Demethyl-4-cholesteryloxypenclomedine [DM-CHOC-PEN] in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies. 2, 1-2.

C Doyle (2017) What do we still need to know about adolescent and young adult survivorship?.

Dekk Unknown Title.

The use of 4-Demethyl-4-cholesteryloxypenclomedine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies Involving the  Central Nervous System (CNS)

Published

2021-03-28

How to Cite

The use of 4-Demethyl-4-cholesteryloxypenclomedine [DM-CHOC-PEN] as Therapy in Adolescent and Young Adult (AYA) Subjects with Advanced Malignancies Involving the Central Nervous System (CNS). (2021). Global Journal of Medical Research, 21(F1), 31-33. https://doi.org/10.34257/GJMRFVOL21IS1PG31